Gujarat Institute of Bioinformatics, Gujarat State Biotechnology Mission, Department of Science & Technology, Government of Gujarat, Gandhinagar, 382011, India.
Gujarat Biotechnology Research Centre (GBRC), Department of Science & Technology, Government of Gujarat, Gandhinagar, 382011, India.
Sci Rep. 2018 May 2;8(1):6935. doi: 10.1038/s41598-018-25281-3.
Leptospirosis is the most widespread zoonotic disease, estimated to cause severe infection in more than one million people each year, particularly in developing countries of tropical areas. Several factors such as variable and nonspecific clinical manifestation, existence of large number of serovars and asymptomatic hosts spreading infection, poor sanitation and lack of an effective vaccine make prophylaxis difficult. Consequently, there is an urgent need to develop an effective vaccine to halt its spread all over the world. In this study, an immunoinformatics approach was employed to identify the most vital and effective immunogenic protein from the proteome of Leptospira interrogans serovar Copenhageni strain L1-130 that may be suitable to stimulate a significant immune response aiding in the development of peptide vaccine against leptospirosis. Both B-cell and T-cell (Helper T-lymphocyte (HTL) and cytotoxic T lymphocyte (CTL)) epitopes were predicted for the conserved and most immunogenic outer membrane lipoprotein. Further, the binding interaction of CTL epitopes with Major Histocompatibility Complex class I (MHC-I) was evaluated using docking techniques. A Molecular Dynamics Simulation study was also performed to evaluate the stability of the resulting epitope-MHC-I complexes. Overall, this study provides novel vaccine candidates and may prompt further development of vaccines against leptospirosis.
钩端螺旋体病是最广泛流行的动物源性传染病,估计每年有超过 100 万人受到严重感染,尤其是在热带地区的发展中国家。一些因素,如多变和非特异性的临床表现、大量血清型和无症状宿主传播感染、卫生条件差以及缺乏有效的疫苗,使得预防变得困难。因此,迫切需要开发一种有效的疫苗来阻止其在全球范围内的传播。在这项研究中,我们采用免疫信息学方法从钩端螺旋体 interrogans 血清型 Copenhageni 菌株 L1-130 的蛋白质组中鉴定出最关键和有效的免疫原性蛋白,该蛋白可能适合刺激显著的免疫反应,有助于开发针对钩端螺旋体病的肽疫苗。对保守且最具免疫原性的外膜脂蛋白进行了 B 细胞和 T 细胞(辅助性 T 淋巴细胞 (HTL) 和细胞毒性 T 淋巴细胞 (CTL))表位预测。进一步,使用对接技术评估了 CTL 表位与主要组织相容性复合体 I (MHC-I) 的结合相互作用。还进行了分子动力学模拟研究,以评估所得表位-MHC-I 复合物的稳定性。总的来说,这项研究提供了新的疫苗候选物,并可能进一步推动针对钩端螺旋体病的疫苗的开发。